Abstract
Fabry disease is a chronic orphan condition that represents both a burden for patients and a financial challenge for the healthcare system. The disease progression is associated with complications affecting the heart, brain, and kidneys. The objective is to determine the comparative costs associated with the complications related to Fabry disease, in patients treated with enzyme replacement therapy in Colombia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
